Changes in Plasma Phospholipid Metabolism Are Associated with Clinical Manifestations of Systemic Sclerosis
Systemic sclerosis (SSc) is an autoimmune disease with fibrosis of the skin and/or internal organs, causing a decrease in quality of life and survival. There is no causative therapy, and the pathophysiology of the SSc remains unclear. Studies showed that lipid metabolism was relevant for autoimmune...
Main Authors: | Marija Geroldinger-Simić, Thomas Bögl, Markus Himmelsbach, Norbert Sepp, Wolfgang Buchberger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/11/2116 |
Similar Items
-
Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis
by: Thomas Bögl, et al.
Published: (2022-03-01) -
The Unyielding Enigma
by: Hima John, et al.
Published: (2024-12-01) -
Clinical course and potential associated factors of progressive calcinosis cutis in early systemic sclerosis: a cohort study
by: Vassana Kanjanajarurat, et al.
Published: (2025-12-01) -
Case of calcinosis cutis associated with Sjogren's syndrome
by: Keysha Gonzalez‐Ramos, et al.
Published: (2023-06-01) -
Idiopathic calcinosis cutis presenting as iliac region mass in an elderly female: A rare entity with cyto-histopathological correlation
by: Nehal Ahmad, et al.
Published: (2024-05-01)